Obsidian Therapeutics

Obsidian develops engineered cell and gene therapies for oncology. Its lead program is a TIL therapy for melanoma that reduces systemic toxicity.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2021